Posted On: 09/09/2015 10:41:27 AM
Post# of 72447
Re: NotRichYet2 #13535
Wow, VTAE up 80%, also I see that AKBA is up about 50% on its good trial results.
I am prejudiced but don't you think completion of Phase 1 in a novel first-in-class cancer therapy would be worth more than that percentage up?
I am prejudiced but don't you think completion of Phase 1 in a novel first-in-class cancer therapy would be worth more than that percentage up?
(0)
(0)
